News

BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) — Nevakar Inc., a specialty pharmaceutical company developing multiple differentiated products in the ophthalmic and injectable areas, announced today that it has entered into a $20 million senior secured term loan with Oxford Finance LLC. As part of the financing agreement, Nevakar may also access an additional $10